• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Thursday 12/14/2017
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Medical

  • 4:36 PM

    TORONTO, Dec. 7, 2017, EHVVF, /PRNewswire/ — Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced that the Company has begun applying machine learning to its large and growing trove of patient data to develop algorithms capable of delivering patient insights on diagnosis and treatment plans for clinicians, into Ehave’s flagship cloud-based informatics platform.  These new capabilities will eventually be offered alongside the integrated gold-standard psychological assessment tools for mental healthcare

    Read more
  • 6:50 AM

    NEW YORK, AITB, (GLOBE NEWSWIRE) — AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections and pulmonary hypertension, today announced publication of its Phase 2, double-blind, randomized controlled trial for treatment of infants with moderately severe bronchiolitis.  The article, entitled Nitric Oxide Inhalations in Bronchiolitis: A Pilot, Randomized, Double-Blinded, Controlled Trial was published in the December 2017 issue of the peer-reviewed Pediatric Pulmonology journal. “We are pleased to see

    Read more
  • 6:35 AM

    Majority of Financing from New Investors PR Newswire BETHESDA, Md., Dec. 4, 2017 BETHESDA, Md., Dec. 4, 2017, NWBO, /PRNewswire/ — Northwest Biotherapeutics (OTCQB: NWBO) (NWBio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has completed a $12 million financing to fund operations.  The majority of the financing is being provided by new investors. The financing is in the form of Series A Convertible Preferred Stock and Warrants.  The Preferred Stock will be convertible into common stock,

    Read more
  • 4:22 PM

    TORONTO, Nov. 28, 2017, EHVVF,  /PRNewswire/ — Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today provided an update on the launch of its digital patient intake system. As of this announcement, Ehave has registered over 24,000 patients into its flagship informatics platform and is maintaining over 700,000 patient resources, including medical documents, medication requests, medication dispenses and psychological assessments. These users have all been integrated into the Ehave Platform, whose recent upgrade leverages the

    Read more
  • 12:08 PM

    No Serious Adverse Events Related to Treatment with Nitric Oxide Reported Compelling Preliminary Data on Key Secondary Endpoint of 6-Minute Walk NEW YORK, Nov. 27, 2017, AITB, (GLOBE NEWSWIRE) — AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections and pulmonary hypertension, today announced that preliminary results from its NO-NTM Phase 2 study in Nontuberculous Mycobacteria (NTM) targeting patients suffering from Mycobacterium Abscessus Complex (MABSC)

    Read more
  • 12:02 PM

    Reflects expanding health and medical media coverage of Milestone’s technologies LIVINGSTON, NJ — MLSS, (Marketwired) — 11/28/17 — Milestone Scientific Inc . (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Wand® STA Dental and CompuFlo® Epidural systems were featured in separate television news broadcasts in Pittsburgh and South Florida, respectively. In addition, news of the commercial launch of the newly developed cosmetic instrument for delivery of botulinum toxin (such as

    Read more
Public Wire Banner